Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00214773|
Recruitment Status : Unknown
Verified January 2019 by BioMarin Pharmaceutical.
Recruitment status was: Recruiting
First Posted : September 22, 2005
Last Update Posted : January 22, 2019
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||July 2020|
|Estimated Study Completion Date :||December 2020|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Solanki GA, Sun PP, Martin KW, Hendriksz CJ, Lampe C, Guffon N, Hung A, Sisic Z, Shediac R, Harmatz PR; CSP Study Group. Cervical cord compression in mucopolysaccharidosis VI (MPS VI): Findings from the MPS VI Clinical Surveillance Program (CSP). Mol Genet Metab. 2016 Aug;118(4):310-8. doi: 10.1016/j.ymgme.2016.06.001. Epub 2016 Jun 3.